Searched for
ARCH CHEMICAL
Shree Karni Fabcom debuts with 15% premium on NSE SME platformShree Karni Fabcom's IPO listed on NSE SME platform with a 14.5% premium. Investors subscribed over 200 times, raising Rs 42 crore for capi...
Boeing CEO warns supply-chain constraints could last ‘Very Long Time'Aircraft manufacturers have struggled to increase production at a time when airlines are clamouring for new jets to meet the surge in trave...
India imposes anti-dumping duty on ursodiolAn industry expert said China had been “unfairly dumping” the chemical, which had brought down its local price from $350 a kg in 2018 to $1...
India initiates anti-dumping probe against Chinese pharma chemicalIf it is established that the dumping has caused material injury to the domestic players, the DGTR would recommend the imposition of anti-d...
Elie Saab's HQ damaged, home gutted in Beirut blast, but designer says 'we must go on'Saab, who began his label during Lebanon's civil war, said the blast revived those memories.
Jayalalithaa confident Prime Minister will be 'neutral' vis-a-vis Cauvery issueShe said it was only fair to give the BJP government some time before it acts on her demand to constitute the Cauvery Management Board.
CVCI buyout helps Rohatyn with India investmentsSale is part of Citigroup’s move to comply with the Volcker Rule mandating banks to exit their alternative investments.
Eight FDI proposals in pharma for Rs 1,842.55 cr approved: Srikant Kumar JenaGovt said a total of eight proposals amounting to Rs 1,842.55 cr relating to FDI in brownfield pharma sector were approved in August this y...
- Mitsui & Co buys additional 25% stake in Arch Pharmalabs for Rs 372 crore
Mitsui is buying out the stakes of IL&FS Trust Co, IDBI Trusteeship Services and Rainbow Fund, according to an application to the FIPB.
Givers' glowThey say helping others helps the helper, through the mediation of powerful feel-good chemicals unleashed by acts of generosity.
- World's biggest maker of drug ingredients Lonza Group AG to buy Arch Chemicals for $1.2 billion
Lonza Group AG agreed to buy Arch Chemicals Inc. for $1.2 billion in cash to create the world's biggest microbial - control business.
- DSM in talks to supply Lipitor ingredient
The Indian subsidiary of the e9.3-billion Dutch chemicals major DSM has started talks with a few global pharma majors to supply atorvastati...
- Ranbaxy can't pop Orchid easily
Solrex will have to fork out an extra Rs 400-500 crore to buy a further 20% stake in case it comes with an open offer.
- Arch Pharmalabs Ltd changing horizons
The entrepreneurial bug bit him at a very young age of 22 and the outcome was a financial services company. In 1998 his life changed track,...
- Arch Pharmalabs in manufacturing tie-up with DSM
Arch Pharmalabs expects to earn $100 million by 2010 from the bulk drug manufacturing deal it has entered into with chemicals group DSM, an...
- DSM Anti Infectives, Arch in strategic pact
Global multispeciality chemical company, DSM has entered into a manufacturing agreement with pharma major Arch Pharmalabs for manufacturing...
- Arch Pharmalabs acquires Watsol Organics
Crug maker Arch Pharmalabs has acquired Watsol Organics for Rs 30 crore.